Replies to post #84742 on OWC Pharmaceutical Research Corp (OWCP)

[kbaz]

That's why dilution risk is minimal The 10K was very standard with the exception of the added news on the development plan for the Multiple Myeloma studies. IP and Science backing along with the addition of Marketing partners continues to be the News to watch for. It will be interesting to see how this is interpreted as the news was more progressive than regressive. Still a lot of Demand wants to own some of the float. Their weapon is likely going to be fear. An already large Short Interest position and a less than yielding retail longs has this Ticker in one helluva battle. Looking forward to a summer of fun... GLTA